Αρχειοθήκη ιστολογίου

Κυριακή 1 Απριλίου 2018

Immunomodulatory Effects of Momordica charantia Extract in the Prevention of Oral Cancer

In recent times, bitter melon extract (BME) has gained significant attention for its anticancer efficacy against various malignancies. In this issue, Sur and colleagues show that BME prevents the development of 4-nitronitroquinoline 1-oxide–induced oral dysplasia and squamous cell carcinoma (SCC) in an immunocompetent mouse model. Importantly, gene ontology and pathway analyses revealed an elevated expression of s100a9, IL23a, IL1β, and PDCD1/PD1 of immune system during oral cancer development, which was significantly suppressed by BME. Overall, this study demonstrates the potential clinical benefits of BME in preventing and delaying the progression of oral dysplasia to SCC. Cancer Prev Res; 11(4); 185–6. ©2018 AACR.

See related article by Sur et al., p. 191



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader https://ift.tt/2pYIWh3

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου